Loading clinical trials...

Straberi Microneedling For Atrophic Acne | Clinical Trials | Clareo Health

COMPLETEDNA

Straberi Microneedling For Atrophic Acne

Clinical Trial Study for the Use of Straberi Microneedling Device to Treat Atrophic Acne Scarring

NCT04740268•Universal Skincare Institute

Summary

This pilot study will expand knowledge and application needling using the Straberi microneedling device for the improvement of Atrophic Acne Scarring

Detailed Description

This pilot study will expand the knowledge and application of needling using the Straberi microneedling device and its safety and benefits for improving the appearance of atrophic acne scarring. The pilot aims to objectively measure skin quality using the Derma Scan, photographs, and provide objective data showing improvement by way of the Goodman and Barons quantitative scar scale.

Eligibility

Age

21 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Derma Scan showing aging including skin texture, wrinkles, brown spots, and pores.
•Patients willing to sign informed consent.
•Patients willing to be photographed and video documented
•Patients willing to consent to 3 months of treatment

Exclusion Criteria

•History of eczema in the treatment area; psoriasis and any other chronic skin conditions
•History of actinic (solar) keratosis in the treatment area;
•History of hemophilia
•History of diabetes
•The presence of raised moles, warts on the targeted area.
•Collagen vascular diseases or cardiac abnormalities
•Blood clotting problems
•Active bacterial or fungal infection
•Facial melanosis
•Malignant tumors
+14 more criteria

Locations (1)

Lavish Beauty

New York, New York, United States

Key Dates

Start Date

December 23, 2022

Primary Completion Date

June 30, 2023

Completion Date

October 12, 2023

Last Updated

December 6, 2023

Enrollment

ACTUAL participants

Conditions

Atrophic Acne Scar

Interventions

Straberi

DEVICE

Evaluation of the Efficacy and Safety of Microneedling Combined With Botulinum Toxin-A Versus Meso-Botox Injection in the Treatment of Atrophic Acne Scars: A Split-face Comparative Study

NCT06544993

Atrophic Acne Scar

View study

COMPLETEDNA

Autologous Plasma Gel Injection Versus Polydioxanone Cog Threads Insertion for the Treatment of Atrophic Post-acne Scars: a Split-face

NCT06580691

Acne VulgarisAtrophic Acne Scar

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 6, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Straberi Microneedling For Atrophic Acne

Inclusion Criteria

Exclusion Criteria

Evaluation of the Efficacy and Safety of Microneedling Combined With Botulinum Toxin-A Versus Meso-Botox Injection in the Treatment of Atrophic Acne Scars: A Split-face Comparative Study

Autologous Plasma Gel Injection Versus Polydioxanone Cog Threads Insertion for the Treatment of Atrophic Post-acne Scars: a Split-face

The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area

Ultherapy® for the Treatment of Acne Scars